Study S002515

The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05578352
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: UNKNOWN
Enrollment: 20
Start: 2022-08-05
Primary completion: 2023-01-31
Lead sponsor: Nanjing First Hospital, Nanjing Medical University
Conditions: Type 2 Diabetes Mellitus
Interventions: OTHER:Add oral hyppoglycemia drug; OTHER:Add GLP-1 receptor agonist; OTHER:Change insulin
Results posted: FALSE

Registered primary outcomes

Insulin autoimmune antibody [3 month]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.